Hangzhou Longshine Bio-Tech Co Ltd
Is this your company? Claim this profile
Drug Product
Company Overview
About
Hangzhou Longshine Bio-Tech Co Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:China
Founded:2007
Employees:1,607
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval HEI469
EMA · #APR-JSFHAGLB · 2021-07-01
Drug Approval X96D7F
FDA · #APR-96MVF27S · 2021-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-57IPC2OK
Issued: 2020-04-25
Expires: 2025-06-11
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-TNVWL7RF
Issued: 2020-02-06
Expires: 2025-10-06
Loading CDMO intelligence...
Key facts about Hangzhou Longshine Bio-Tech Co Ltd
- Hangzhou Longshine Bio-Tech Co Ltd is headquartered in China.
- Hangzhou Longshine Bio-Tech Co Ltd was founded in 2007.
- Hangzhou Longshine Bio-Tech Co Ltd has 1,607 employees.
- Hangzhou Longshine Bio-Tech Co Ltd's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Hangzhou Longshine Bio-Tech Co Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.